Precision BioSciences to Participate in Upcoming Stifel Genetic Medicines Day

Author's Avatar
May 24, 2023

Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that the Company will participate in the Stifel Genetic Medicines Day taking place May 30, 2023.